1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Frequency of procedure-related adverse events according to PRU
Quartile (No.) PRU Thromboembolic Events Procedure-Related Aneurysmal Perforations All Procedure-Related Adverse Events 1st (47) <240 2 (4.3%) 1 (2.1%) 3 (6.4%) 2nd (46) 240–284 1 (2.2%) 0 (0%) 1 (2.2%) 3rd (46) 285–332 3 (6.5%) 0 (0%) 3 (6.5%) 4th (47) >332 8 (17.0%) 2 (4.3%) 10 (21.3%) P valuea .013 .605 .009
a χ2 test for trends.